威雅利(00854.HK)將委任執行董事梁智恆為董事會主席
格隆匯11月14日丨威雅利(00854.HK)發佈公吿,因梁振華先生決定專注於個人事務及為有利於董事會更新及有序繼任,其已提出辭任公司董事會主席及公司非執行董事,於2023年1月1日生效。因此,梁振華先生亦將於同日不再擔任公司僱員購股權計劃委員會主席。為順利完成工作過渡,梁振華先生將會繼續擔任上述職務直至2022年12月31日。隨着梁振華先生辭任董事會主席及非執行董事職務,彼將被聘請為公司策略顧問,自2023年1月1日起生效。
委任公司執行董事梁智恆,為董事會主席,自2023年1月1日生效。梁智恆先生將取代梁振華先生的職務,出任ESOS委員會主席,自2023年1月1日生效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.